Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Cancer × anlotinib × Clear all

NCT05896059 2023-06-09

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

Phase 2 Unknown

Extensive Stage Small Cell Lung Cancer

NCT04933175 2021-06-21

Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer

Phase 2 Unknown

Extensive Stage Small Cell Lung Cancer